[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555774":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":36,"responsibleParty":56,"collaborators":10,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Shirley Ryan AbilityLab","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observation",null,"Gait quality observation",[13],"Diagnostic Test: Camera Based Kinematic Analysis",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIAGNOSTIC_TEST","Camera Based Kinematic Analysis","Observational Study using Camera Based, Marker Less Kinematic Analysis of gait quality of persons with Multiple Sclerosis",[9],[21],"OpenCap",[23],{"name":24,"affiliation":5,"role":25},"Milap Sandhu, PhD","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Weena Dee","CONTACT","312-328-7503","wdee@sralab.org",{"name":33,"role":29,"phone":34,"phoneExt":10,"email":35},"Alex Barry","312-238-1435","abarry@sralab.org",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Chicago","Illinois","60611","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-87.65005,41.85003,{"lat":48,"lon":47},[51,54],{"name":52,"role":29,"phone":53,"phoneExt":10,"email":31},"Weena Dee, DPT","312-238-7503",{"name":55,"role":29,"phone":34,"phoneExt":10,"email":35},"Alex Barry, MS,CCRC",{"type":25,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Milap Sandhu","Principal Investigator","100555774","development-of-camera-based-gait-quality-measure-for-persons-with-multiple-sclerosis-100555774",false,"NCT06516458","Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis","Development of Camera Based Gait Deviation Index for Persons With Multiple Sclerosis","MS-GDI","Inclusion criteria:\n\n* Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)\n* Able to ambulate overground\n* Relapse free for at least 1 month\n* Age ≥18 and ≤ 75 years\n* Participants using dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening\n\nExclusion criteria:\n\n\\- Orthopedic injuries, fractures, surgeries or other conditions affecting locomotor function or weight bearing","ALL","18 Years","75 Years",{"count":71,"type":72},40,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).",[76,77,78,79],"Multiple Sclerosis","Multiple Sclerosis, Secondary Progressive","Multiple Sclerosis Relapse","Multiple Sclerosis, Relapsing-Remitting","2024-07-18",{"date":82,"type":83},"2024-07-24","ACTUAL",{"date":85,"type":72},"2024-07",{"date":87,"type":72},"2026-07",{"name":5,"class":6},1]